Could your pain be related to Rheumatoid Arthritis?
Learn about the signs and symptoms of Rheumatoid Arthritis and the options available for treatment.
Having trouble identifying pills? Try the Pill Identifier
Quickly identify pills, tablets and capsules using the web’s most comprehensive Pill Identification Wizard.
Worried about drug interactions? Use the Interactions Checker
The drug interactions tool allows you to check for drug-drug and drug-food interactions.
Discover treatment options with the new Symptom Checker
This interactive decision guide helps identify the underlying cause of common symptoms.
Custom search for Medical Transcriptionists?
Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.
Welcome to Drugs.com
Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products. Find helpful tools, wallet size personal medication records, mobile applications and more.
Featured Topic Centers
- MedFacts Drug Information
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- MedFacts Natural Products
Fulyzaq
Fulyzaq (crofelemer) is a proanthocyanidin oligomer indicated to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral ...
Sirturo
Sirturo (bedaquiline) is an oral diarylquinoline antimycobacterial drug indicated for the treatment of pulmonary multi-drug resistant ...
Eliquis
Eliquis (apixaban) is a factor Xa inhibitor anticoagulant indicated to reduce the risk of stroke and systemic embolism in patients with ...
Sugammadex
Sugammadex is a novel selective relaxant binding agent (SRBA) specifically designed to reverse the effects of
rocuronium bromide ...
vortioxetine
Vortioxetine is a multimodal antidepressant in development for the treatment of major depressive disorder (MDD).
Zohydro
Zohydro ER (hydrocodone) is a single-entity (without acetaminophen)
extended-release opioid analgesic for around the clock management of ...
Daily Medical News
RSSIs 'Untreatable' Gonorrhea On the Way?
TUESDAY, Jan. 8 -- The sexually transmitted disease gonorrhea is becoming increasingly resistant to available antibiotics, including the last oral antibiotic used to treat the bacterium, new Canadian research shows. In a study of nearly 300 people infected with Neisseria gonorrhoeae, the researchers found a treatment failure rate of nearly 7 percent in people treated with cefixime, the last...
How Much Caffeine in That Supplement? Hard to Tell
TUESDAY, Jan. 8 -- A new study finds that popular supplement pills and powders found for sale at many military bases, including those that claim to boost energy and control weight, often fail to properly describe their caffeine levels. Some of these products -- also sold at health-food stores across the county -- didn't provide any information about caffeine on their labels despite being packed...
Vitamin D Doesn't Improve Knee Arthritis, Study Finds
TUESDAY, Jan. 8 -- Taking vitamin D supplements does not reduce pain or cartilage loss in people with knee osteoarthritis, researchers have found. Some prior studies had suggested that vitamin D might benefit these patients. "Vitamin D is a very hot topic in medicine and many people in the United States have low vitamin D levels," noted one expert not connected to the study, Dr. Diane Horowitz,...
Latest Pharma Industry News
RSSMany Doctors Prescribe Costlier Drugs Than Needed, Study Finds
Many Doctors Prescribe Costlier Drugs Than Needed, Study Finds [Milwaukee Journal Sentinel] From Milwaukee Journal Sentinel (WI) (January 8, 2013) Jan. 08--More than a third of doctors said they prescribe brand name drugs simply because patients ask for them even when cheaper generics would be appropriate, according to a new study. The practice, which can contribute to higher health care...
Death Rates for Most Major Cancers Decline Slightly
Death Rates for Most Major Cancers Decline Slightly [the Pittsburgh Tribune-Review] From Pittsburgh Tribune-Review (PA) (January 8, 2013) Jan. 07--Top researchers on Monday reported a slight decline in overall cancer death rates nationwide over a 10-year period but an increase in the incidence of some cancers, prompting a renewed call for prevention efforts. Cancer death rates declined for...
FDA approves Kineret for the treatment of NOMID
Sobi (STO: SOBI) today announced that the US Food and Drug Administration (FDA) has approved Kineret® (anakinra) for the treatment of children and adults with neonatal-onset multisystem inflammatory disease (NOMID). Kineret is the first and only FDA-approved therapy for NOMID, the most severe form of cryopyrin associated periodic syndromes (CAPS). This is the first approval allowing the...
Latest Additions to Drugs.com
Recently added consumer and prescribing information: Fulyzaq, Sirturo, Eliquis, Juxtapid, Adasuve, Raxibacumab, Raxibacumab, Gattex, Signifor, Iclusig ...also see new filings.
Transparency in Clinical Trials: A New Paradigm Shift?
The British Medical Journal (BMJ), a leading, peer-reviewed medical journal, has announced that beginning in January 2013 it will require all authors of drug or device clinical trials who publish in BMJ – whether industry-funded or not – to provide detailed scientific study data to anyone with a reasonable request. Although the policy specifics are ...
Q3 2012 Drug Sales Data Released: Nexium and Abilify Remain the Leading Brands
The latest U.S. drug sales data has been released by Drugs.com. As in the previous quarter, proton-pump inhibitors, antipsychotics and statins remain in the top-selling therapeutic categories. Merck’s asthma and allergy preventive Singulair predictably drops out of the top five drugs due to Q3 patent loss. AstraZeneca’s Nexium, not forecast to lose patent protection until May 2014, ...
Bristol-Myers Squibb Acquisition Results in $1.8 Billion Loss
Bristol-Myers Squibb (BMS) has announced that they will discontinue all development of their chronic hepatitis C (HCV) treatment BMS-986094, a nucleotide polymerase (NS5B) inhibitor previously in Phase 2 clinical trials. BMS reports that nine study patients were hospitalized with heart and kidney toxicity, with one patient death due to heart failure. The exact cause of ...